FIELD: medicine, pharmacy. SUBSTANCE: invention relates to curative agent exhibiting sedative and anxiolytic effect. Agent comprises components taken in the following ratio, wt.%: guaifenesin, 3.5-4.5; vegetable extract, 5-15; sodium benzoate, 0.3-0.4; sodium cyclamate, 0.4-0.6; sodium saccharinate, 0.08-0.1; sodium citrate, 0.3-0.45; citric acid, 0.09-0.15; glucose, 0-25; fructose, 15-42; xanthane gum, 0.05-0.15; propylene glycol, 8-12; dextrin, 7-9; dye, 0-0.05; aromatic essence, 0.01-0.1; ethyl alcohol, 5-12; and purified water, the balance. EFFECT: expanded assortment of sedative and anxiolytic agents. 4 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION "FITO NOVO-SED" ELICITING SEDATIVE AND ANXIOLYTIC PROPERTY | 2003 |
|
RU2241486C1 |
AGENT "FITOSEDATIN" SHOWING SEDATIVE EFFECT | 2001 |
|
RU2185847C1 |
PREPARATION FLAVOSUCCINE FOR TREATING AND PREVENTING RENAL AND URINARY DISEASES | 2010 |
|
RU2456011C1 |
MUCOLYTIC AGENT "BROMHEXINE-FEREIGN" | 2001 |
|
RU2212234C1 |
SEDATIVE AGENT AND METHODS FOR ITS PREPARING | 2005 |
|
RU2291705C1 |
SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION, HAVING NOOTROPIC ACTIVITY | 2018 |
|
RU2703293C1 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
"LAMIVIT" PREPARATION TO INCREASE BODY ADAPTATIONAL RESPONSES | 2001 |
|
RU2183127C1 |
"BRAVEGYL" ANTIHISTAMINE PRODUCT | 2002 |
|
RU2205638C1 |
Authors
Dates
2003-02-27—Published
2001-12-29—Filed